Product
Pyridostigmine
Aliases
Mestinon, Pyridostigmine Bromide
Name
Mestinon
INN Name
pyridostigmine bromide
FDA Approved
Yes
8 clinical trials
1 organization
10 indications
1 document
Indication
Orthostatic HypotensionIndication
Spinal Muscular Atrophy Type 3Indication
Postdural Puncture HeadacheIndication
HIVIndication
Non-HIVIndication
Vagus Nerve DysfunctionIndication
ME/CFSIndication
Postural Tachycardia SyndromeIndication
Myasthenia GravisIndication
Postoperative IleusClinical trial
Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine HypertensionStatus: , Estimated PCD: 2025-05-01
Clinical trial
Safety and Efficacy Study of Anti-cholinesterase Therapy on the Motor Functions in Patients With Spinal Muscular Atrophy Type 3.Status: Completed, Estimated PCD: 2017-07-01
Clinical trial
Addition of Pyridostigmine to Conventional Management of Postdural Puncture HeadacheStatus: Completed, Estimated PCD: 2024-01-03
Clinical trial
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIVStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)Status: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
IMproving Symptomatic Treatment With Pyridostigmine and Amifampridine: a Randomized Double-blinded, Placebo Controlled Crossover Trial in Patients With Myasthenia Gravis (IMPACT-MG)Status: Recruiting, Estimated PCD: 2024-09-22
Clinical trial
Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery (PESTI Trial)Status: Not yet recruiting, Estimated PCD: 2025-12-01
Document
DailyMed Label: MestinonOrganization
Bausch Health US, LLC